Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsNA

Vibration Exercise for Crohn's to Observe Response

Sponsor: University of Hertfordshire

NCT ID: NCT06211400

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Access to the study treatment being tested
Type of study
Interventional (receives a drug or procedure)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Whole body vibration exercise (other)
How long the study runs
Study runs about 34 months (dates as stated)
About the drug or intervention
Whole body vibration exercise — other: 6-week supervised whole body vibration exercise programme (training sessions three times per week lasting 10 min) alongside a lifestyle education programme
Patient visit burden
Not specified by the sponsor
Type of study
Testing a treatment
Ages
18 Years to 65 Years
Who
All
Number of participants
168
Started
2025-03-31
Last checked
2025-07

Plain English Summary

What is this study?

  • • Testing a new treatment for crohn's disease
  • • NA - 168 participants
  • • Background: Crohn's disease (CD) is a long-term inflammatory condition of the digestive system

Who can take part?

  • • Ages 18 Years to 65 Years
  • • Diagnosed with crohn's disease

Where?

  • • Hatfield - University of Hertfordshire

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

Background: Crohn's disease (CD) is a long-term inflammatory condition of the digestive system. People with CD often have unpredictable and debilitating symptoms, including abdominal pain, diarrhoea and fatigue. In addition, they require long-term treatment with frequent negative effects and often need surgery and hospitalisations. Therefore, people with CD report a lower health-related quality of life (HRQOL) compared with other people. Doctors are constantly trying to find new treatments to improve HRQOL and control symptoms and whole body vibration exercise could be a potential treatment. Exercise might be a simple, safe, and low-cost intervention for improving HRQOL in people with CD. This is because it has the potential to improve several aspects of physical, mental and social well-being simultaneously. Adults with CD have been shown to be less active than the general population and do not meet the recommended daily physical activity guidelines. One barrier to exercise is lack of time, however whole-body vibration exercise (where you stand and squat on a vibrating plate) can be done over a much shorter duration and at a lower intensity to gain potentially similar or at times greater benefits. More research is needed to understand the effects, both positive and negative of vibration exercise in people with CD. Aim: This study begins to understand whether undertaking a supervised 6-week vibration exercise programme for adults with mild to moderately active Crohn's disease improves HRQoL and other symptoms such as fatigue.

Crohn's Disease

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years - 65 Years
  • Who can join: All genders

What the study is looking for

  • ✓Aged over 18-65 years old
  • ✓Clinical diagnosis of CD for at least 4 weeks before randomization
  • ✓Mild to moderate active CD (150-220 CDAI)
  • ✓Stable medication for at least 4 weeks before randomization
  • ✓Able to provide written consent, complete the study questionnaires and travel to the research centre for study...

Who cannot take part

  • ✗Over 65 years old Severe or uncontrolled medical conditions that make it undesirable for the patient to participate
  • ✗Coexistent serious autoimmune disease such as rheumatoid arthritis or systemic sclerosis
  • ✗Planned major surgery within the first 3 months after randomization
  • ✗Are pregnant, or are planning pregnancy within the first 3 months after randomization
  • ✗Poor tolerability to venepuncture or lack of adequate venous access for required blood sampling
See the full criteria
Inclusion Criteria: * Aged over 18-65 years old * Clinical diagnosis of CD for at least 4 weeks before randomization * Mild to moderate active CD (150-220 CDAI) * Stable medication for at least 4 weeks before randomization * Able to provide written consent, complete the study questionnaires and travel to the research centre for study assessment visits and exercise sessions * Be doing less than 60 minutes of purposeful exercise per week Exclusion Criteria: * Over 65 years old Severe or uncontrolled medical conditions that make it undesirable for the patient to participate * Coexistent serious autoimmune disease such as rheumatoid arthritis or systemic sclerosis * Planned major surgery within the first 3 months after randomization * Are pregnant, or are planning pregnancy within the first 3 months after randomization * Poor tolerability to venepuncture or lack of adequate venous access for required blood sampling * Current participation in \>60 min/week of purposeful exercise, such as jogging or cycling * Participation in another clinical trial for which concurrent participation is deemed inappropriate * Any orthopaedic implants (hip, knee, spine)

Where Is This Study? (1 UK site)

University of Hertfordshire

Hatfield AL10 9EU, United Kingdom

Recruiting
Site contact (verified)

How to Get in Touch

Lindsay Bottoms

Sponsor contact

CONTACT

+441707285685 l.bottoms@herts.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2025-07